Dennis Dean Sells 24,510 Shares of AirSculpt Technologies, Inc. (NASDAQ:AIRS) Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) CEO Dennis Dean sold 24,510 shares of AirSculpt Technologies stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $6.54, for a total value of $160,295.40. Following the completion of the transaction, the chief executive officer now directly owns 582,052 shares of the company’s stock, valued at approximately $3,806,620.08. This represents a 4.04 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Dennis Dean also recently made the following trade(s):

• On Wednesday, November 13th, Dennis Dean sold 7,719 shares of AirSculpt Technologies stock. The stock was sold at an average price of $7.53, for a total transaction of $58,124.07.

AirSculpt Technologies Price Performance

AIRS opened at $6.51 on Friday. The company’s 50-day simple moving average is $5.60 and its two-hundred day simple moving average is $4.76. AirSculpt Technologies, Inc. has a 52-week low of $2.92 and a 52-week high of $9.20. The stock has a market capitalization of $376.81 million, a P/E ratio of -46.50 and a beta of 1.57. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.86 and a current ratio of 0.51.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings data on Friday, November 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). AirSculpt Technologies had a negative net margin of 4.13% and a positive return on equity of 2.22%. The company had revenue of $42.55 million for the quarter, compared to the consensus estimate of $42.49 million. During the same quarter last year, the company earned ($0.01) EPS. As a group, analysts predict that AirSculpt Technologies, Inc. will post 0.15 EPS for the current year.

Analyst Ratings Changes

Separately, BTIG Research assumed coverage on AirSculpt Technologies in a research report on Thursday, October 17th. They issued a “neutral” rating on the stock.

Institutional Trading of AirSculpt Technologies

A number of hedge funds have recently bought and sold shares of the company. Barclays PLC boosted its position in AirSculpt Technologies by 227.0% in the third quarter. Barclays PLC now owns 19,100 shares of the company’s stock worth $97,000 after purchasing an additional 13,259 shares during the last quarter. FourWorld Capital Management LLC bought a new position in shares of AirSculpt Technologies in the 1st quarter worth approximately $557,000. Geode Capital Management LLC grew its position in AirSculpt Technologies by 6.4% during the third quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after buying an additional 21,339 shares during the period. Vanguard Group Inc. increased its holdings in AirSculpt Technologies by 1.0% during the first quarter. Vanguard Group Inc. now owns 576,038 shares of the company’s stock valued at $3,537,000 after buying an additional 5,606 shares during the last quarter. Finally, SW Investment Management LLC raised its position in AirSculpt Technologies by 5.0% in the second quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock worth $18,000,000 after acquiring an additional 213,677 shares during the period. Hedge funds and other institutional investors own 91.54% of the company’s stock.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.